Search results
UBS Group AG Has $167.76 Million Stock Holdings in Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 3 days agoUBS Group AG trimmed its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 9.9% during the fourth quarter, according to its most recent disclosure with the Securities ...
Level Four Advisory Services LLC Cuts Stock Position in Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 4 days agoLevel Four Advisory Services LLC trimmed its holdings in shares of Novartis AG (NYSE:NVS – Free Report) by 5.9% during the 4th quarter, according to the company in its most ...
A corner of the cancer therapy market is heating up—Here are the names investors need to know
CNBC· 14 hours agoThere's been a lot of attention lately on a corner of the oncology market called radiopharmaceuticals. The therapy seeks to destroy cancer cells by binding a radioactive particle to a targeted ...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
CNBC· 14 hours agoBig pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall...
Drugmaker Novartis to expand nuclear medicine factory near airport, creating 55 jobs - Indianapolis...
Indianapolis Business Journal· 4 days agoA Swiss-based drugmaker plans to double the size of its Indianapolis manufacturing plant, which produces nuclear medicine imaging and therapy products for cancer, in a move that would create ...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 13 hours agoNote: So-called late-breaking abstracts, which often feature particularly consequential trial findings, aren’t available until the day the relevant...
Erasca restructures; Novartis moves to complete MorphoSys deal
BioPharma Dive via Yahoo Finance· 7 days agoThe cancer biotech is laying off one-fifth of its staff and scrapping three drugs. Elsewhere, ...
Updates in Parkinson's, ICH, Migraine, Muscular Dystrophy
Medscape· 1 day agoProf Christoph Diener discusses his picks for updates in neurology that were published in April...
Latest 340B ruling delivers blow to providers
Healthcare Dive· 2 days agoThe ruling is a win for drug manufacturers, who were previously threatened with fines from the federal government for violating guidance regarding which pharmacies they would send discounted ...
Exploring Swiss Dividend Stocks In May 2024
Simply Wall St. via Yahoo Finance· 2 hours agoThe Switzerland market displayed resilience, closing slightly up on Thursday amidst a backdrop of mixed corporate updates and European economic data. The...
